Researchers are working feverishly to discover effective treatments for COVID-19. One drug showing early promise is remdesivir, which is being studied with the help of GW alumnus Richard Whitley, MD ’71, of the University of Alabama at Birmingham.
The BioCompute Object Specification Project led by a team at SMHS has been officially approved for publication as an internationally recognized standard by the Institute of Electrical and Electronics Engineers Standards Association.
To contain the flood of information on COVID-19, faculty and staff across GW are developing weekly intelligence reports for frontline providers and leaders throughout the GW medical enterprise.
Washington, D.C., taps GW expertise to help develop a plan to reopen the city following weeks of manditory stay at home orders in the face of the COVID-19 pandemic.
Every day Americans face myriad hardships as the COVID-19 pandemic continues without end. One major challenge is mental health.
A survey from the George Washington University evaluated whether patients consider a dermatologist’s social media presence when looking for a doctor